Abstract
Introduction

35
Type 2 diabetes mellitus (T2DM) is a progressive disease characterized by decreasing 36 sensitivity of peripheral tissues to plasma insulin accompanied by compensatory 37 hyperinsulinemia, and a gradual failure of the pancreatic islet β-cells to maintain glucose 38 homeostasis. The worldwide prevalence of diabetes is projected to increase from 451 million 39 in 2017 to 693 million by 2045
1 . In the past decade, the use of data-driven omics technologies 40 has led to a significant advancement in the discovery of new biomarkers for complex disease. Pearson's r ranging from -0.60 to 0.97 (Fig. S2a) . A pathway and gene ontology (GO) 89 enrichment analysis of all 520 proteins associated with prevalent T2DM revealed an 90 enrichment of proteins involved in extracellular matrix (ECM)-receptor interaction, 91 complement and coagulation cascades, metabolic processes and extracellular region (Fig. 92 S3a, Table S3 ). We furthermore found the genes encoding the 520 prevalent T2DM-93 associated proteins to be enriched for high expression in liver, followed by other tissues that 94 included kidney, gastrointestinal tract and pancreas (Fig. S4a) . Thus, the diabetic state is 95 reflected in a major shift in the serum proteome that is involved in metabolic, inflammatory 96 and ECM processes.
98
Serum protein profile of incident T2DM
99
The serum protein profiles of T2DM patients observed in the cross-sectional analysis 100 described above may represent shifts that occurred either before or after the onset of the with incident T2DM were also associated with prevalent T2DM (Fig. 1c) , an overlap that was 112 highly significant (Fisher's exact test P = 7.2×10 -63 ), and the direction of effect was generally 113 consistent (Spearman's correlation coefficient = 0.82, Fig. 1d-f expression enrichment analysis revealed a strong enrichment for genes expressed in liver,
121
followed by adipose tissue (Fig. S4b) . Thus, the functional annotation of the serum proteins 122 associated with incident T2DM was characterized by tissue specific signatures and pathways 123 that seem to reflect dyslipidemia and insulin resistance, which are critical in the development 124 of T2DM. We compared our findings with previously described protein biomarker candidates 125 for incident T2DM as previously reviewed 11 . Of 58 previously suggested candidates that were 126 targeted in our study, we found 26 to be at least nominally associated (P < 0.05) with incident 127 T2DM in our data and additional 15 with prevalent T2DM (Table S5) .
129
Predictive performance of protein biomarkers for incident T2DM
130
As it is of considerable interest to define a set of biomarkers for clinical prediction of T2DM,
131
we aimed to define the subset of proteins associated with incident T2DM that had the best 2.8×10 -4 ), respectively ( Fig. 2a-b , Table 2 ). The observed increase in AUC was considerably 155 greater than for randomly sampled sets of proteins (Fig. 2b) of which 184 (75%) proteins had more than one independent (r 2 < 0.1) instrument (Table S7) .
180
On average, we identified 5 (range 1 -20) genetic instruments per protein (Fig. S9) but ranked by the number of times they were chosen in the LASSO bootstrap analysis.
397
We assessed discrimination or differentiation between T2DM cases and non-cases Table S2 . Serum protein associations with prevalent T2DM in the AGES cohort (n = 5,438).
568
Results are shown for logistic regression models adjusted for age and sex, or age, sex and 569 BMI. P adj , Bonferroni corrected P-value. Table S7 . An overview of the associations between the cis-SNPs used as instruments for the 589 246 proteins that were included in the MR analysis.
570
590 Table S8 . Two-and one-sample Mendelian randomization results for 48 T2DM-associated 591 proteins that were significantly (P < 0.05) associated with T2DM in the two-sample MR 592 analysis. The colors denote significant associations with prevalent T2DM (blue), incident T2DM (red) or both (yellow). e) Violin and boxplots showing serum protein levels across the AGES cohort stratified by T2DM status for top three proteins associated with prevalent T2DM and f) incident T2DM. Stars denote significant difference compared to the non-diabetic group with nominal P-values (two-sided t-test) as such: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. Boxplots indicate median value, 25 th and 75 th percentile, whiskers extend to smallest/largest value no further than 1.5×IQR, outliers not shown. pT2DM, prevalent T2DM; iT2DM, incident T2DM in participants with AGESII follow-up visit; iT2DM rec , incident T2DM in participants without AGESII follow-up visit. 3 Forest plot for the 48 proteins supported as causal (P < 0.05) in the two-sample MR analysis, together with the number of SNPs used as instruments and the MR P-value. MR estimates were obtained using the inverse variance weighted method when >1 SNP was available for a given protein, but otherwise with the Wald ratio. 1  1  2  1  2  2  6  1  4  3  12  6  15  12  8  9  12  14  19  16  13  6  12  8  12  12  8  6  14  4  2  7  2  9  4  4  2  3  1  5  1  4  1  1  1  1  1  1   FABP4  RBP7  AMY2B  IGFALS  INHBC  PCBD1  CCDC126  HDGF  ATP1B2  ART3  KNG1  COL6A1  MLN  GDF15  NFASC  LAMC2  MTHFS  IL18R1  ERAP2  COLEC11  SEMA4D  TNFSF12  TNFAIP6  FAM3B  WFIKKN2  HIBCH  CRTAC1  FAM177A1  MMP12  PIGR  SHMT1  FABP1  AFM  PLXNB2  SEMA3G  A4GALT   DNER  GNPNAT1  SHBG  B3GALT6  DBNL  IGSF3  PYGL  MENT  FAM20B  CAMP  IGFBP4 LGALS3BP
Fig. S1
Workflow of the current study. The top left Venn diagram provides an overview of the AGES cohort, stratified by T2DM status and follow-up visit participation. The workflow is divided into three major steps; 1) identifying proteins associated with prevalent or incident T2DM using logistic regression analysis, 2) identifying a panel of proteins for multivariate prediction of incident T2DM using a LASSO bootstrap analysis, followed by internal validation using a separate part of the AGES cohort, and 3) combining genetic data from AGES and summary statistics from the DIAMANTE T2DM GWAS to screen all T2DM-associated proteins for potential causality using a Mendelian randomization analysis. pT2DM, prevalent T2DM; iT2DM, incident T2DM in participants with AGESII follow-up visit; iT2DMrec, incident T2DM in participants without AGESII follow-up visit. Scatterplots for the three proteins with P < 0.05 and directionally consistent in both the twoand one-sample MR analyses and more than one genetic instrument, demonstrating the estimated effects (with 95% confidence intervals) of their respective genetic instruments on the protein levels in AGES (x-axis) and the risk of T2DM in a) the DIAMANTE GWAS (y-axis) and b) in the AGES cohort. 
